CASI Pharmaceuticals (NASDAQ:CASI) Coverage Initiated by Analysts at StockNews.com
StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report report published on Friday. The firm issued a hold rating on the biotechnology company’s stock. CASI Pharmaceuticals Price Performance Shares of CASI opened at $2.09 on Friday. The company has a debt-to-equity ratio of 1.38, a quick ratio of […]
StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report report published on Friday. The firm issued a hold rating on the biotechnology company’s stock. CASI Pharmaceuticals Price Performance Shares of CASI opened at $2.09 on Friday. The company has a debt-to-equity ratio of 1.38, a quick ratio of […]
